| P50 | author | Norbert Zilka | Q88314056 |
| P2093 | author name string | Mangesh Bhide | |
| | Ondrej Bugos | |
| P2860 | cites work | Genome sequence of the Brown Norway rat yields insights into mammalian evolution | Q22122498 |
| | Amyloid plaque core protein in Alzheimer disease and Down syndrome | Q24568384 |
| | A comparative study on the integration of exogenous DNA into mouse, rat, rabbit, and pig genomes | Q73944641 |
| | Advances in transgenic rat production | Q79158024 |
| | Generation of rat mutants using a coat color-tagged Sleeping Beauty transposon system | Q80448597 |
| | Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene | Q82110587 |
| | Sperm-mediated gene transfer | Q82553018 |
| | Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease | Q94029459 |
| | Mild ALS in Japan associated with novel SOD mutation | Q72751018 |
| | Phylogenetics of the laboratory rat Rattus norvegicus | Q73165325 |
| | Functional genomics and rat models | Q73198566 |
| | Generation of transgenic rats with YACs and BACs: preparation procedures and integrity of microinjected DNA | Q73277894 |
| | Production of transgenic rats for human regulators of complement activation | Q73321656 |
| | Sperm-mediated gene transfer: advances in sperm cell research and applications | Q73326470 |
| | Why map the rat? | Q73344543 |
| | Genetic isolation of quantitative trait loci for blood pressure development and renal mass on chromosome 5 in the spontaneously hypertensive rat | Q73488575 |
| | Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 |
| | Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats | Q28582143 |
| | Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis | Q28592161 |
| | Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells | Q28748618 |
| | Use of Transgenic Animals to Improve Human Health and Animal Production | Q29029045 |
| | Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors | Q29547596 |
| | Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology | Q29617284 |
| | Neurodegenerative tauopathies | Q29619895 |
| | Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically | Q33321335 |
| | Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease | Q33582860 |
| | Transgenic models of Alzheimer's disease: learning from animals | Q33844718 |
| | Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). | Q34010341 |
| | Production of transgenic rats by lentiviral transduction of male germ-line stem cells | Q34380449 |
| | New gene transfer methods | Q34484124 |
| | Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats | Q34521275 |
| | Sperm-mediated gene transfer: applications and implications | Q34650453 |
| | Progress and prospects in rat genetics: a community view. | Q34774643 |
| | Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension | Q34790141 |
| | Heritable and stable gene knockdown in rats | Q34983927 |
| | Identification of early disease progression in an ALS rat model | Q35809308 |
| | Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction | Q35972119 |
| | Phosphorylated tau and the neurodegenerative foldopathies | Q35992172 |
| | Lentiviral transgenesis | Q36021017 |
| | DNA transposons in vertebrate functional genomics | Q36072055 |
| | Relations between animal transgenesis and reproduction | Q36176525 |
| | Transgenic modifications of the rat genome | Q36295015 |
| | Transgenic animal production and animal biotechnology | Q36637184 |
| | Finding diamonds in the rubble | Q36766001 |
| | New technology for an old favorite: lentiviral transgenesis and RNAi in rats | Q36903592 |
| | Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. | Q37087752 |
| | Use of genetically modified rat models for translational medicine | Q37189991 |
| | Animal models of Alzheimer's disease and frontotemporal dementia | Q37196122 |
| | Mechanisms of neurodegeneration in Huntington's disease. | Q37202865 |
| | Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies | Q37308954 |
| | Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51 | Q37542016 |
| | The rat as an experimental animal | Q38664018 |
| | Sexual dimorphism in disease onset and progression of a rat model of ALS. | Q40233416 |
| | Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS. | Q40296129 |
| | Disease progression of human SOD1 (G93A) transgenic ALS model rats | Q40366167 |
| | O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). | Q40399756 |
| | Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament | Q40871850 |
| | Production of transgenic mice from vitrified pronuclear-stage embryos. | Q41616749 |
| | Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene | Q41832311 |
| | Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males | Q42436584 |
| | Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease | Q42508306 |
| | NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy | Q43407063 |
| | Offspring derived from intracytoplasmic injection of transgenic rat sperm | Q44020564 |
| | Rescue of infertile transgenic rat lines by intracytoplasmic injection of cryopreserved round spermatids. | Q44060562 |
| | Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells. | Q44076350 |
| | Transgenic rat model of Huntington's disease | Q44350467 |
| | Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation | Q45297722 |
| | Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats | Q45300103 |
| | Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat. | Q45300444 |
| | Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel | Q45300462 |
| | Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington's disease | Q45302126 |
| | Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. | Q45302545 |
| | Generation and characterization of a GFP transgenic rat line for embryological research | Q45761587 |
| | Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models | Q46571223 |
| | Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis | Q46863053 |
| | Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis | Q46935339 |
| | Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex | Q47332094 |
| | Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo | Q47411323 |
| | Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. | Q47751488 |
| | Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. | Q47992709 |
| | A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation | Q48165977 |
| | Efficient transgenic rat production by a lentiviral vector | Q48261790 |
| | Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats | Q48337886 |
| | Progression of morphological changes within CNS in a transgenic rat model of familial amyotrophic lateral sclerosis | Q48397363 |
| | Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. | Q48510520 |
| | Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. | Q48511374 |
| | Maintenance of the rat transgenic model of familial amyotrophic lateral sclerosis expressing human SOD1G93A mutation | Q48653167 |
| | Direct comparison between ICSI-mediated DNA transfer and pronuclear DNA microinjection for producing transgenic rats. | Q48756422 |
| | Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load | Q48969704 |
| | Factors affecting production of transgenic rats by ICSI-mediated DNA transfer: effects of sonication and freeze-thawing of spermatozoa, rat strains for sperm and oocyte donors, and different constructs of exogenous DNA. | Q49089872 |
| | Production of transgenic rats via lentiviral transduction and xenogeneic transplantation of spermatogonial stem cells. | Q50625118 |
| | Production of transgenic rats by ooplasmic injection of spermatogenic cells exposed to exogenous DNA: a preliminary study. | Q50672495 |
| | Efficient generation of transgenic mice with intact yeast artificial chromosomes by intracytoplasmic sperm injection. | Q50672632 |
| | Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. | Q50886605 |
| | Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production. | Q51835448 |
| | A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. | Q51956350 |
| | Comparison between PMSG- and FSH-induced superovulation for the generation of transgenic rats. | Q53960427 |
| | Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats. | Q54693722 |
| | Efficiency of transgenic rat production is independent of transgene-construct and overnight embryo culture | Q56963560 |
| | A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition | Q57114177 |
| | Alzheimer's disease | Q57526464 |
| | Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene | Q59066147 |
| P433 | issue | 6-7 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 859-869 | |
| P577 | publication date | 2009-03-05 | |
| P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
| P1476 | title | Beyond the rat models of human neurodegenerative disorders | |
| P478 | volume | 29 | |